SNCA and Parkinson disease: The chaperone function of α2M has been demonstrated in vitro using a broad range of misfolded clients including denatured globular proteins and aggregation prone, intrinsically disordered substrates (e.g., Aβ peptide and Parkinson's disease-associated alpha-synuclein).